Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

17-10-2022 | Editorial

European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees

Authors: Rudi Dierckx, Ken Herrmann, Roland Hustinx, Michael Lassmann, Wolfgang Wadsak, Jolanta Kunikowska

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 1/2022

Excerpt

The American Society for Radiation Oncology (ASTRO) and the ASTRO board of directors approved in the fall of 2021 a new framework for radiopharmaceutical therapy curriculum development for trainees, which was published by Ana P. Kiess et al. [1]. Being members of the European Association of Nuclear Medicine (EANM) Board, we want to comment officially on behalf of the EANM. …

Kiess AP, Hobbs RF, Bednarz B, Knox SJ, Meredith R, Escorcia FE. ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees. Int J Radiat Oncol Biol Phys. 2022;113(4):719–26. https://doi.org/10.1016/j.ijrobp.2022.03.018.CrossRefPubMed

Goldsmith SJ. Targeted radionuclide therapy: a historical and personal review. Semin Nucl Med. 2020;50:87–97. https://doi.org/10.1053/j.semnuclmed.2019.07.006.CrossRefPubMed

Rowe SP, Pomper MG. Molecular imaging in oncology: current impact and future directions. CA Cancer J Clin. 2022;72(4):333–52. https://doi.org/10.3322/caac.21713.CrossRefPubMed

Bodei L, Herrmann K, Schöder H, Scott AM, Lewis JS. Radiotheranostics in oncology: current challenges and emerging opportunities. Nat Rev Clin Oncol. 2022;19(8):534–50. https://doi.org/10.1038/s41571-022-00652-y.CrossRefPubMed

Herrmann K, Schwaiger M, Lewis JS, Solomon SB, McNeil BJ, Baumann M, et al. Radiotheranostics: a roadmap for future development. Lancet Oncol. 2020;21(3):e146–56. https://doi.org/10.1016/S1470-2045(19)30821-6.CrossRefPubMedPubMedCentral

O Sartor, J de Bono, KN Chi, K Fizazi, K Herrmann, et al for the VISION Investigators¹⁷⁷Lutetium-–PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med 2021; 385. 1091–1103. https://doi.org/10.1056/NEJMoa2107322.

EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022. ISBN 978–94–92671–16–5.

Aerts A, Eberlein U, Holm S, Hustinx R, Konijnenberg M, Strigari L, et al. EANM position paper on the role of radiobiology in nuclear medicine. Eur J Nucl Med Mol Imaging. 2021;48:3365–77. https://doi.org/10.1007/s00259-021-05345-9.CrossRefPubMedPubMedCentral

Pouget JP., Konijnenberg M, Eberlein U, Glatting G, Gabina PM, Herrmann K et al, EANM position paper on advancing radiobiology for shaping the future of nuclear medicine. Eur J Nucl Med Mol Imaging 2022; 2022 https://doi.org/10.1007/s00259-022-05934-2.

10.

Herrmann K, Giovanella L, Santos A, Gear J, Kiratli PO, Kurth J, et al. Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre. Eur J Nucl Med Mol Imaging. 2022;49:2300–9. https://doi.org/10.1007/s00259-022-05785-x.CrossRefPubMedPubMedCentral

Title: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees
Authors: Rudi Dierckx
Ken Herrmann
Roland Hustinx
Michael Lassmann
Wolfgang Wadsak
Jolanta Kunikowska
Publication date: 17-10-2022
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 1/2022
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-022-06011-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Correction to: [18F]FAPI‑42 PET/CT versus [18F]FDG PET/CT for imaging of recurrent or metastatic gastrointestinal stromal tumors

[18F]FAPI-42 PET/CT versus [18F]FDG PET/CT for imaging of recurrent or metastatic gastrointestinal stromal tumors

Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PET

Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga]Ga-PSMA-11 PET/CT images

Beyond equality, women require extra care in cardiovascular imaging

Quantitative PET imaging of the CD4 pool in nonhuman primates